Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consolidation in the Spinal Implant Market

Executive Summary

This is the second big deal in the spinal implant market in the last three months. With its acquisition of Acromed, DePuy establishes itself as a strong Number 2 in what company officials believe is the fastest growing market in orthopedics today. Moreover, it did so at a fraction of the price Sulzer paid to get SpineTech just a couple of years earlier. While industry officials shake their heads at Sulzer's largesse, company officials are betting that SpineTech's cage technology represents a breakthrough product in spinal implants.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV000883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel